TMCnet News

Research and Markets: Blood Screening Market - Global Market Research 2015-2019 - Adoption of NAAT
[November 02, 2015]

Research and Markets: Blood Screening Market - Global Market Research 2015-2019 - Adoption of NAAT


Research and Markets (http://www.researchandmarkets.com/research/k5db4s/blood_screening) has announced the addition of the "Blood Screening Market - Global Market Research 2015-2019" report to their offering.

About blood screening

The report forecasts the global blood screening market to grow at a CAGR of 9.31% over the period 2014-2019.

The report, Global Blood Screening Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global blood screening market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

The report covers the current scenario and the growth prospects of the global blood screening market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of instruments, assays/consumables, and services for the technologies such as NAAT and multiplexed real-time PCR (News - Alert)

Blood screening is a medical process where blood is scanned for testing of particular condition or disease. his procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. The major blood tests that are extensively used for diagnosing diseases include erythrocyte sedimentation rate (ESR), full blood count (FBC), electrolyte test, karyotyping, enzyme-linked immunosorbent assay (ELISA), C-reactive protein, liver function test, and blood cholesterol test. The market for blood screening has witnessed numerous technological advances such as shift toward the first-generation ELISA to highly advanced NAAT testing, since its inception.



Key vendors:

  • Abbott Diagnostics
  • bioMérieux
  • Grifols
  • Roche Diagnostics

Other prominent vendors:


  • Alere
  • BD
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic
  • Immunetics
  • Lab21
  • Meridian Bioscience
  • OraSure
  • Ortho Clinical Diagnostics
  • Qiagen
  • SeraCare
  • Siemens (News - Alert) Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by technology

Part 07: Market segmentation by product

Part 08: Geographical segmentation

Part 09: Market drivers

Part 10: Impact of drivers

Part 11: Market challenges

Part 12: Impact of drivers and challenges

Part 13: Market trends

Part 14: Vendor landscape

Part 15: Key vendor analysis

Part 16: Appendix

For more information visit http://www.researchandmarkets.com/research/k5db4s/blood_screening


[ Back To TMCnet.com's Homepage ]